| Q28547847 | A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APPSweDI Mice |
| Q48663844 | A redox-based chemical delivery system that enhances estradiol distribution to the brain: disposition studies in the rat |
| Q48923555 | A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog. |
| Q36350461 | A ¹¹C-labeled 1,4-dihydroquinoline derivative as a potential PET tracer for imaging of redox status in mouse brain |
| Q48663341 | Brain, Blood, and Cerebrospinal Fluid Distribution of a Zidovudine Chemical Delivery System in Rabbits |
| Q38840950 | Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster. |
| Q35812095 | Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue |
| Q54049611 | Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection. |
| Q33933498 | Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics |
| Q39994950 | Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity |
| Q41735596 | Drug targeting via retrometabolic approaches |
| Q45132603 | Ether, carbonate and urethane deoxynucleoside derivatives as prodrugs |
| Q48800538 | Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice |
| Q48709260 | In vitro and in vivo investigations of dihydropyridine-based chemical delivery systems for anticonvulsants |
| Q73850558 | Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system |
| Q48091937 | Recent advances in retrometabolic design approaches |
| Q33904251 | Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems |